A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
Clinical trial NCT06742190 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06742190
- Sponsor
- argenx
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2026-09-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.